What are CML Community Advisory Boards (CML-CABs)?

CML Community Advisory Board (CML-CAB) is a global panel of 19 leading patient advocates from all world regions (“CML-CAB members”) who all represent the unique perspective of a CML patient or relative.

CML-CAB members work together to address issues of strategic importance to the community at large and advocate for the best possible research and equal access to the most innovative treatment & care for CML patients around the world.

CML-CAB monitors pharmaceutical developments and research in CML through active and targeted interaction, long-term cooperation and continued dialogue with pharmaceutical partners, regulators, medical experts, and the scientific CML-community.

To learn more about CML Community Advisory Boards, watch our CML-CAB video.